Filing Details
- Accession Number:
- 0001708138-20-000084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-09 16:29:38
- Reporting Period:
- 2020-07-07
- Accepted Time:
- 2020-07-09 16:29:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1585160 | E Robert Landry | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-07-07 | 10,000 | $555.67 | 33,973 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-07-07 | 9,321 | $640.88 | 24,652 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2020-07-07 | 2,500 | $399.66 | 27,152 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-07-07 | 2,019 | $640.88 | 25,133 | No | 4 | F | Direct | |
Common Stock | Disposition | 2020-07-08 | 24 | $634.14 | 25,109 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-08 | 585 | $636.50 | 24,524 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-08 | 40 | $637.40 | 24,484 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-08 | 45 | $638.99 | 24,439 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-08 | 80 | $639.88 | 24,359 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-08 | 43 | $640.32 | 24,316 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-08 | 48 | $642.93 | 24,268 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-08 | 104 | $643.84 | 24,164 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-08 | 57 | $645.99 | 24,107 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-08 | 37 | $646.18 | 24,070 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-08 | 94 | $648.54 | 23,976 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-08 | 3 | $650.41 | 23,973 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-07-07 | 2,500 | $0.00 | 2,500 | $399.66 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-07-07 | 10,000 | $0.00 | 10,000 | $555.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
31,500 | 2024-12-16 | No | 4 | M | Direct | |
10,000 | 2025-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 200 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 585 shares of Company stock on July 8, 2020 at prices ranging from $636.22 to $636.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 8, 2020 at each separate price.
- Represents volume-weighted average price of sales of 104 shares of Company stock on July 8, 2020 at prices ranging from $643.81 to $643.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 8, 2020 at each separate price.
- Represents volume-weighted average price of sales of 94 shares of Company stock on July 8, 2020 at prices ranging from $648.23 to $648.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 8, 2020 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.